| Different methods to determine the encapsulation efficiency of protein in PLGA nanoparticles Y Amini, S Amel Jamehdar, K Sadri, S Zare, D Musavi, M Tafaghodi Bio-medical materials and engineering 28 (6), 613-620, 2017 | 75 | 2017 |
| High prevalence of blaCMY AmpC beta-lactamase in ESBL co-producing Escherichia coli and Klebsiella spp. clinical isolates in the northeast of Iran KS Rizi, A Mosavat, M Youssefi, SA Jamehdar, K Ghazvini, H Safdari, ... Journal of global antimicrobial resistance 22, 477-482, 2020 | 46 | 2020 |
| Aluminum hydroxide nanoparticles show strong activity to stimulate Th-1 immune response against tuberculosis Y Amini, B Moradi, M Fasihi-Ramandi Artificial cells, nanomedicine, and biotechnology 45 (7), 1331-1335, 2017 | 43 | 2017 |
| Prevalence of Legionella species in water resources of Iran: a systematic review and meta-analysis A Khaledi, A Bahrami, E Nabizadeh, Y Amini, D Esmaeili Iranian journal of medical sciences 43 (6), 571, 2018 | 34 | 2018 |
| CD73; a key ectonucleotidase in the development of breast cancer: Recent advances and perspectives A Soleimani, E Taghizadeh, S Shahsavari, Y Amini, H Rashidpour, ... Journal of cellular physiology 234 (9), 14622-14632, 2019 | 30 | 2019 |
| Diversity of aminoglycoside modifying enzymes and 16S rRNA methylases in Acinetobacter baumannii and Acinetobacter nosocomialis species in Iran; wide distribution of aadA1 and armA H Salimizand, AR Zomorodi, D Mansury, M Khakshoor, O Azizi, ... Infection, Genetics and Evolution 66, 195-199, 2018 | 30 | 2018 |
| Development of an effective delivery system for intranasal immunization against Mycobacterium tuberculosis ESAT-6 antigen Y Amini, M Tebianian, N Mosavari, M Fasihi Ramandi, SM Ebrahimi, ... Artificial cells, nanomedicine, and biotechnology 45 (2), 291-296, 2017 | 29 | 2017 |
| Enhancement of the effect of BCG vaccine against tuberculosis using DDA/TDB liposomes containing a fusion protein of HspX, PPE44, and EsxV D Mansury, K Ghazvini, S Amel Jamehdar, A Badiee, M Tafaghodi, ... Artificial Cells, Nanomedicine, and Biotechnology 47 (1), 370-377, 2019 | 27 | 2019 |
| Molecular characterization and genetic relatedness of clinically Acinetobacter baumanii isolates conferring increased resistance to the first and second generations … Z Meshkat, H Salimizand, Y Amini, M Khakshoor, D Mansouri, H Farsiani, ... Annals of Clinical Microbiology and Antimicrobials 16, 1-6, 2017 | 25 | 2017 |
| The therapeutic potential of targeting CD73 and CD73-derived adenosine in melanoma A Soleimani, HK Farshchi, F Mirzavi, P Zamani, A Ghaderi, Y Amini, ... Biochimie 176, 21-30, 2020 | 21 | 2020 |
| Increasing cellular immune response in liposomal formulations of DOTAP encapsulated by fusion protein Hspx, PPE44, and Esxv, as a potential tuberculosis vaccine candidate D Mansury, K Ghazvini, SA Jamehdar, A Badiee, M Tafaghodi, ... Reports of biochemistry & molecular biology 7 (2), 156, 2019 | 21 | 2019 |
| Immunological assessment of chitosan or trimethyl chitosan-coated PLGA nanospheres containing fusion antigen as the novel vaccine candidates against tuberculosis S Zare, M Kabiri, Y Amini, A Najafi, F Mohammadpour, SH Ayati, ... Aaps Pharmscitech 23, 1-14, 2022 | 19 | 2022 |
| T helper type 1 biased immune responses by PPE17 loaded core-shell alginate-chitosan nanoparticles after subcutaneous and intranasal administration A Najafi, K Ghazvini, M Sankian, L Gholami, Y Amini, S Zare, F Khademi, ... Life Sciences 282, 119806, 2021 | 16 | 2021 |
| TB trifusion antigen adsorbed on calcium phosphate nanoparticles stimulates strong cellular immunity in mice Y Amini, B Moradi, M Tafaghodi, Z Meshkat, K Ghazvini, ... Biotechnology and Bioprocess Engineering 21, 653-658, 2016 | 15 | 2016 |
| ISAba1/blaOXA-23-like family is the predominant cause of carbapenem resistance in Acinetobacter baumannii and Acinetobacter nosocomialis in Iran Z Meshkat, Y Amini, H Sadeghian, H Salimizand Infection, Genetics and Evolution 71, 60-66, 2019 | 12 | 2019 |
| Construction of a novel DNA vaccine candidate encoding an HspX-PPE44-EsxV fusion antigen of Mycobacterium tuberculosis B Moradi, M Sankian, Y Amini, Z Meshkat Reports of biochemistry & molecular biology 4 (2), 89, 2016 | 12 | 2016 |
| Chitosan nanoparticles containing fusion protein (Hspx–PPE44–EsxV) and resiquimod adjuvant (HPERC) as a novel booster vaccine for Mycobacterium tuberculosis R Hoseinpur, A Hasani, B Baradaran, J Abdolalizadeh, Y Amini, R Salehi, ... Journal of Biomaterials Applications 37 (1), 40-47, 2022 | 10 | 2022 |
| Determining a pattern for antibiotic resistance in clinical isolations of Pseudomonas aeruginosa. SS Zahedani, M Jahantigh, Y Amini | 10 | 2018 |
| Heterologous expression, purification, and characterization of the HspX, Ppe44, and EsxV proteins of Mycobacterium tuberculosis Y Amini, M Tafaghodi, SA Jamehdar, Z Meshkat, B Moradi, M Sankian Reports of biochemistry & molecular biology 6 (2), 125, 2018 | 9 | 2018 |
| Cloning, expression and purification of HpaA recombinant protein of helicobacter pylori as a vaccine candidate A Khaledi, A Bahador, D Esmaeili, M Derakhshan, M Mahdavi, J Amani, ... Journal of Pure and Applied Microbiology 10 (3), 1937-1941, 2016 | 9 | 2016 |